HAM-net-registered patients observed for at least one year (n = 434) | |
---|---|
Sex: Female | 327 (75.3%) |
Age at baseline (year)a | 61.9 ± 10.6 |
Age at onset (year)a | 44.4 ± 14.8 |
Disease durationa (time from onset to the baseline) | 16.3 ± 11.1 |
Baseline OMDSa | 5.7 ± 2.2 |
Rapid progressorsb | 83 (19.1%) |
Comorbidities | Incidence per 1000 person-yearsc |
Uveitis | 6.5 (3.3–12.7) |
Sjogren’s syndrome | 0.8 (0.1–4.3) |
Rheumatoid arthritis | 3.0 (1.2–7.7) |
All Bone Fracture | 55.5 (44.0–69.8) |
OMDS 1–4 | 35.9 (19.5–66.1) |
OMDS 5 | 57.4 (39.2–84.2) |
OMDS 6 | 73.2 (46.3–115.8) |
OMDS 7–13 | 56.0 (35.4–88.6) |
Lower limb fracture | 22.6 (15.8–32.3) |
OMDS 1–4 | 3.5 (0.6–19.6) |
OMDS 5 | 23.7 (13.3–42.5) |
OMDS 6 | 24.1 (11.1–52.6) |
OMDS 7–13 | 36.8 (21.0–64.3) |
Compression fracture | 22.4 (15.7–32.0) |
OMDS 1–4 | 10.6 (3.6–31.1) |
OMDS 5 | 19.3 (10.1–36.6) |
OMDS 6 | 44.0 (24.6–78.9) |
OMDS 7–13 | 20.7 (10.0–42.8) |
Upper limb fracture | 3.7 (1.6–8.6) |
Herpes zoster | 10.4 (6.2–17.4) |
Interstitial pneumonia | 1.5 (0.4–5.4) |
Tuberculosis | 0.0 (0.0–2.8) |
Diabetes mellitusd | 6.2 (3.1–12.2) |
Cataractd | 9.4 (5.4–16.5) |
Glaucomad | 2.3 (0.8–6.7) |